These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24616129)

  • 41. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of sulfonamidoethylenediamine substituents in Ru
    Chen F; Soldevila-Barreda JJ; Romero-Canelón I; Coverdale JPC; Song JI; Clarkson GJ; Kasparkova J; Habtemariam A; Brabec V; Wolny JA; Schünemann V; Sadler PJ
    Dalton Trans; 2018 May; 47(21):7178-7189. PubMed ID: 29651471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide.
    Arshad J; Tong KKH; Movassaghi S; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticancer Activity of Iridium(III) Complexes Based on a Pyrazole-Appended Quinoline-Based BODIPY.
    Paitandi RP; Mukhopadhyay S; Singh RS; Sharma V; Mobin SM; Pandey DS
    Inorg Chem; 2017 Oct; 56(20):12232-12247. PubMed ID: 28956596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient catalytic interconversion between NADH and NAD+ accompanied by generation and consumption of hydrogen with a water-soluble iridium complex at ambient pressure and temperature.
    Maenaka Y; Suenobu T; Fukuzumi S
    J Am Chem Soc; 2012 Jan; 134(1):367-74. PubMed ID: 22122737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydrosulfide Adducts of Organo-Iridium Anticancer Complexes.
    Štarha P; Habtemariam A; Romero-Canelón I; Clarkson GJ; Sadler PJ
    Inorg Chem; 2016 Mar; 55(5):2324-31. PubMed ID: 26863200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK; Law WH; Liu HW; Lo KK
    Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications.
    Hao H; Liu X; Ge X; Zhao Y; Tian X; Ren T; Wang Y; Zhao C; Liu Z
    J Inorg Biochem; 2019 Mar; 192():52-61. PubMed ID: 30597449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity.
    Parveen S; Hanif M; Leung E; Tong KKH; Yang A; Astin J; De Zoysa GH; Steel TR; Goodman D; Movassaghi S; Söhnel T; Sarojini V; Jamieson SMF; Hartinger CG
    Chem Commun (Camb); 2019 Oct; 55(80):12016-12019. PubMed ID: 31498360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acidic iridium hydrides: implications for aerobic and Oppenauer oxidation of alcohols.
    Gabrielsson A; van Leeuwen P; Kaim W
    Chem Commun (Camb); 2006 Dec; (47):4926-7. PubMed ID: 17136249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A model iridium hydroformylation system with the large bite angle ligand xantphos: reactivity with parahydrogen and implications for hydroformylation catalysis.
    Fox DJ; Duckett SB; Flaschenriem C; Brennessel WW; Schneider J; Gunay A; Eisenberg R
    Inorg Chem; 2006 Sep; 45(18):7197-209. PubMed ID: 16933920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
    Palanichamy K; Sreejayan N; Ontko AC
    J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenoxide chelated Ir(iii) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity.
    Zhang Y; Zhang S; Tian Z; Li J; Xu Z; Li S; Liu Z
    Dalton Trans; 2018 Oct; 47(39):13781-13787. PubMed ID: 30238113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Inorg Chem; 2013 Jan; 52(2):974-82. PubMed ID: 23301676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligand-promoted dehydrogenation of alcohols catalyzed by Cp*Ir complexes. A new catalytic system for oxidant-free oxidation of alcohols.
    Fujita K; Tanino N; Yamaguchi R
    Org Lett; 2007 Jan; 9(1):109-11. PubMed ID: 17192097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, characterization and catalytic activity of saturated and unsaturated N-heterocyclic carbene iridium(i) complexes.
    Chang YH; Fu CF; Liu YH; Peng SM; Chen JT; Liu ST
    Dalton Trans; 2009 Feb; (5):861-7. PubMed ID: 19156280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.